Skelebenz 15 Capsule ER

Introduction

Skelebenz is a prescription medication that contains the active ingredient Cyclobenzaprine. It is available in the form of extended-release capsules and is used for the treatment of muscle spasms and associated pain.

Uses

Skelebenz is prescribed for the relief of muscle spasms that occur in conditions such as musculoskeletal disorders, such as back pain or injuries. It helps to relax the muscles and alleviate associated pain, allowing for improved mobility and comfort.

Dosage and Administration

The dosage of Skelebenz will vary depending on the severity of the muscle spasms and the individual patient’s response to treatment. Follow the dosage instructions provided by your healthcare professional. Generally, the usual recommended dose is one capsule taken orally once daily, preferably at bedtime. The extended-release formulation allows for a gradual release of the medication over time, providing sustained relief.

Mechanism of Action

Cyclobenzaprine, the active ingredient in Skelebenz, works by acting on the central nervous system to relieve muscle spasms. It inhibits certain nerve impulses that are responsible for the muscle contractions, helping to relax the muscles and reduce pain.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, and blurred vision. These side effects are generally mild and temporary. However, if you experience any severe or persistent side effects, such as rapid heartbeat, hallucinations, or difficulty breathing, seek medical attention immediately.

Drug Interactions

Skelebenz may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and tricyclic antidepressants. These interactions can increase the risk of serotonin syndrome, a potentially life-threatening condition. Inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid any potential drug interactions.

Precautions

Before taking Skelebenz, inform your healthcare professional about any medical conditions you have, especially if you have a history of heart problems, glaucoma, or urinary retention. This medication may not be suitable for everyone, and your healthcare professional will assess your individual circumstances to determine if it is appropriate for you.

Additionally, Skelebenz may cause drowsiness and impair your ability to perform tasks that require alertness. Avoid driving or operating machinery until you know how the medication affects you.

Storage

Skelebenz should be stored at room temperature, away from moisture, heat, and light. Keep the medication in its original container and out of the reach of children.

Patient Tips

• Take Skelebenz exactly as prescribed by your healthcare professional. Do not take more or less than the recommended dose.
• continue taking the medication as directed, even if you start feeling better, unless instructed otherwise by your healthcare professional.
• If you forget to take a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid consuming alcohol while taking Skelebenz, as it may increase the risk of side effects.
• If you have any questions or concerns about the medication, do not hesitate to reach out to your healthcare professional for guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Cyclobenzaprine (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• cyclobenzaprine hcl (RX) [Accessed 1 Jun. 2024] (online) Available at:
• Cyclobenzaprine (MedlinePlus) [Accessed 16 Jun. 2024] (online) Available at:
• [No authors listed] Cyclobenzaprine. 2021 Mar 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 1 Jun. 2024] Available at: